Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Breast 6Genitourinary 5Tumor-Agnostic 3Other 3Lymphoid 3Thoracic 2Sarcoma 2Head & Neck 2Other hematologic neoplasm 1Gynecologic 1Endocrine 1CNS 1

Conditions

Urinary Incontinence, Stress 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Electroacupuncture × Endocrine × Clear all
NCT05773716 2025-07-24

Electroacupuncture and Pelvic Floor Muscle Training for Male Stress Urinary Incontinence

RenJi Hospital

Phase NA Completed
120 enrolled
Endocrine

Urinary Incontinence, Stress, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡